Madrigal Pharmaceuticals, Inc. MDGL Total Assets
Total Assets at other companies
Other financials
Where this comes from
Reported directly by Madrigal Pharmaceuticals, Inc. in its filing.
Tagged under the XBRL concept us-gaap:Assets.
The official record: Madrigal Pharmaceuticals, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Madrigal Pharmaceuticals, Inc.'s total assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Madrigal Pharmaceuticals, Inc.'s total assets?
- Madrigal Pharmaceuticals, Inc. (MDGL) reported total assets of $1.23B in Q1 2026.
- How has Madrigal Pharmaceuticals, Inc.'s total assets changed year-over-year?
- Madrigal Pharmaceuticals, Inc.'s total assets increased by 23.1% year-over-year, from $996.63M to $1.23B.
- What is the long-term trend for Madrigal Pharmaceuticals, Inc.'s total assets?
- Over 5 years (2020 to 2025), Madrigal Pharmaceuticals, Inc.'s total assets has grown at a 34.4% compound annual growth rate (CAGR), from $287M to $1.26B.
- What does total assets mean?
- The total value of everything the company owns.
- How do you interpret total assets?
- An increase suggests capital expansion or asset accumulation, while a decrease may indicate asset liquidation or divestiture.
- How does total assets compare across companies?
- Varies widely based on the stage of drug development and capital intensity of the business model.